This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 07/10/2018
Location: Silver Spring, MD
Subject: Milk Labeling
FDA Participant/Group: Abram, Anna K; Boon, Caitlin S; Boon, Caitlin S; Ostroff, Stephen M; Smith, Candra A; Stearn, Douglas W;
Non FDA Participant/Group: Jeff Aiken (Tennessee Farm Bureau Federation); Justin Ferguson, Mike McCormick (Mississippi Farm Bureau Federation); Ron Gibson (Utah Farm Bureau Federation); Michael Nepveux (The American Farm Bureau Federation); Jim Holte (Wisconsin Farm Bureau Federation);

Event Date: 07/12/2018
Location: Silver Spring, MD
Subject: Food Products Derived from Animal Cell Culture
FDA Participant/Group: Several staff members from FDA
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton , Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/10/2018
Location: Rockville, MD
Subject: Cell & Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality, and Regulatory Considerations
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 07/12/2018
Location: Washington, DC
Subject: American Society of Hematology Summit: Emerging Immunotherapies for Hematologic Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/11/2018
Location: Silver Spring, MD
Subject: Future Collaboration Opportunities
FDA Participant/Group: Yustein, Aron S; Margerrison, Edward; Gross, Thomas P;
Non FDA Participant/Group: Ronni Solomon, Marcus Schabacker, Michael Argentieri (Emergency Care Research Institute(ECRI));

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Rebecca K. Wood, J.D., Chief Counsel

No Significant Event